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FEATURE ARTICLE
LOST IN TRANSLATION?  THE
PROMISES AND PITFALLS OF
ENACTING U.S. BAYH-DOLE
STYLE LEGISLATION IN INDIA
By ANN WEILBAECHER
The Rajya Sabha, India’s Upper House of Parliament, recently began con-sidering a contentious piece of intellectual property legislation modeled
after the U.S. Patent and Trademark Law Amendments Act of 1980 (Bayh-
Dole Act).1  The Protection and Utilisation of Public Funded Intellectual
Property Bill, 2008 (Indian Bayh-Dole Bill) allows universities, rather than the
government, to patent discoveries derived from publicly funded research.2  The
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Indian Bayh-Dole Bill also gives inventors and institutions a share in the royal-
ties and licensing fees generated from the resulting commercial products.3
While proponents argue that the Indian Bayh-Dole Bill will result in greater
interaction among the government, academic institutions and industry, critics
caution that the proposed legislation’s emphasis on commercialization will
threaten the public interest.4  These critics assert that the purported benefits of
the Bayh-Dole Act have been overstated in the U.S., and that the Indian Bayh-
Dole Bill has the potential to hinder innovation and access to essential
medicines and treatments in India.5
U.S. BAYH-DOLE ACT
The Indian Bayh-Dole Bill is closely modeled after the U.S. Bayh-Dole Act,
which gives universities the right to obtain patents on innovations resulting
from government-funded research and to issue exclusive licenses on those pat-
ents.6  Journalists and commentators have referred to the Bayh-Dole Act as
“[p]ossibly the most inspired piece of legislation to be enacted in America over
the past half-century,”7 and “the Magna Carta for university technology
transfer.”8
Proponents report that before the Bayh-Dole Act, thousands of government-
funded inventions were collecting dust in university laboratories across the
U.S.9 According to the U.S. Government Accountability Office, the federal
government owned 28,000 patents and less than five percent of those patents
were licensed to industry.10 Advocates allege that since its inception, “the over-
all effect of the Bayh-Dole Act has been to contribute more than $40 billion
annually to the American economy.”11
BAYH-DOLE EMULATION ABROAD
In the hopes of achieving similar benefits, developing and emerging countries
such as Brazil, South Africa, Malaysia and China have implemented Bayh-Dole
style legislation in the past several years.12  Scholars, however, express concern
that many countries are adopting such legislation based upon faulty assump-
tions about the Act’s efficacy in the U.S.13  They contend that the Bayh-Dole
Act is only one of a number of factors that has lead to increased patenting and
licensing.14  Further, scholars suggest that Bayh-Dole style legislation may even
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inhibit scientific research and innovation in developing countries because too
many patents can lead to overlapping claims and time-consuming disputes.15
India is the most recent example of a country considering enacting legislation
similar to the Bayh-Dole Act. Scholars question the wisdom of transplanting
U.S. style legislation to a country like India, given the different cultural, eco-
nomic, social, and legal context of modern day India compared with the U.S.
in the 1980s when the Bayh-Dole Act was enacted.16  Shamnad Basheer, an
associate at New Delhi’s Oxford Intellectual Property Research Center, asks
rhetorically, “Does it make sense for India to blindly import such a bill, given
that we have a different set of circumstances (in terms of the nature of univer-
sity research, relationship with industry, cultural specificities) than what pre-
vailed in the US in the ’80s?”17  Basheer recommends that the legislators
“study what the specific Indian conditions are and then customize the bill to
those conditions.”18
SECRECY OF THE LEGISLATION
The Union Cabinet, India’s highest executive authority, approved the Indian
Bayh-Dole Bill on October, 31, 2008, before legislators released a draft to the
public.19  Although drafting began in 2005, the Minister of Science and Tech-
nology first disclosed the Indian Bayh-Dole Bill in December 2008, just before
it was formally introduced to Parliament.20  Basheer was instrumental in bring-
ing the bill to the public’s attention, posting unofficial drafts on his website,
Spicy IP, and calling for public interest groups and stakeholders to demand
transparency.21
The secrecy of the legislation has spurred public outcry. “I think it’s part of a
troubling impunity in which governments feel that they can act in debating
these issues that have very important public interest implications,” states Ethan
Guillen, Executive Director of Universities Allied for Essential Medicines
(UAEM), a student-run public interest group.22  “It’s the same trend where
governments go behind closed doors and work with industry-minded groups
to create these policies that are then foisted upon the public without any real
civil society or public interest comment,” says Guillen.23
Some, however, are not as concerned with the lack of transparency.  Naryanan
Suresh, Group Editor of India’s first biotechnology business magazine, Biospec-
159
3
Weilbaecher: Lost in Translation? The Promises and Pitfalls of Enacting U.S. B
Published by LAW eCommons, 2009
26794 lpr_14-2 Sheet No. 23 Side B      06/29/2009   13:47:06
26794 lpr_14-2 Sheet No. 23 Side B      06/29/2009   13:47:06
\\server05\productn\L\LPR\14-2\LPR207.txt unknown Seq: 4 27-MAY-09 10:57
Loyola Public Interest Law Reporter
trum India, points out that there is no set procedure for releasing draft docu-
ments before they are introduced to Parliament.24  In fact, legislators are only
required to publicly disclose documents after they are introduced to Parlia-
ment, according to Suresh.25
While Basheer acknowledges the government acted legally, he asserts that
transparency is a “good norm,” especially with legislation that has such import
to the public interest as the Indian Bayh-Dole Bill.26
GENERATING WEALTH
Proponents argue that the Indian Bayh-Dole Bill will allow universities to reap
financial benefits from their discoveries, and, as a result, jump start scientific
innovation in India.27  According to Suresh, there is widespread support for
the Indian Bayh-Dole Bill among biotech experts who believe the legislation
could spur innovation in the biotech sector like it did in the U.S.28  He adds,
“In India, scientists are no different from scientists anywhere else in the world”
and would be motivated by a bill that allows them to commercialize their
research.29
Under the Indian Bayh-Dole Bill, scientists would be allowed to retain at least
30 percent of the royalties earned from patents and licenses resulting from
government funded research.30  Universities would retain 40 percent of the net
income, and the remaining income would finance the management of intellec-
tual property at the university.31  Unlike the U.S. Bayh-Dole Act, the Indian
Bayh-Dole Bill actually specifies a minimum percentage to which inventors are
entitled.32
India’s Science Minister, Kapil Sibal, expressed confidence that the bill will be
passed, and that it will assist Indian universities to “make millions through
patents.”33  “That statement is pretty deeply misinformed if you think about
universities as a whole in the U.S.,” says Professor Matthew Herder, visiting
intellectual property law professor at Loyola University Chicago School of
Law.34  “There have only been a few universities that have made a lot of
money after Bayh-Dole, and those that have been successful. . .were those that
were successful before for the most part.”35
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According to Basheer, “The costs of operating the technology transfer offices
far exceed the money most universities make out of licensing.”36  He elabo-
rates, “That is why we were very anxious that they disclose the bill at an earlier
stage. I think there’s enough empirical evidence to show that . . . a large num-
ber of universities would not necessarily make money.”37
SAFEGUARDS TO ACCESS
The most pressing concern outlined by public interest groups is that the Indian
Bayh-Dole Bill will threaten access to the fruits of government funded re-
search.  UAEM cautions that the Indian Bayh-Dole Bill will “allow the institu-
tions and their licensees to charge monopoly prices that may place life-saving
medicine out of the reach of India’s poorest consumers, denying them the
opportunity to benefit from publicly-funded research.”38  According to Guil-
len, “The Bayh-Dole Act is at the basis of everything that UAEM is trying to
change.”39
Guillen expresses concern that the Indian Bayh-Dole Bill contains even fewer
safeguards to preserve public access than the Bayh-Dole Act.40  When the Bayh
Dole Act was debated in the U.S., there was an emphasis on preserving pubic
access to the results of publicly funded research.41 As a consequence, a “march-
in right” provision was added whereby if anything was brought to market
under unreasonable circumstances, the government could take action.42  The
Indian Bayh-Dole Bill has no such “march-in right” provision.43
Guillen asserts, however, that the “march-in right” process has been “imperfect
and extremely flawed” in the U.S., because the government has never invoked
these “march-in rights.”44  Herder notes, “What we don’t know is if there are
cases where a license was disseminated broadly because the government said
they were going to invoke march-in rights behind the scenes.”45  He elaborates,
“If they have been used behind the scenes, it can still be a valuable tool.”46
Basheer contends that in an earlier draft of the legislation there was a clause
specifying that the compulsory licensing provisions under the Indian Patent
Act would apply to the Indian Bayh-Dole Bill.47  Compulsory licensing would
have a similar effect as “march-in rights” in that the government could use
patented discoveries for a limited period without the consent of the patent
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holder.48  This clause, however, did not appear in the publicly released version
of the Indian Bayh-Dole Bill.49
When asked about the removal of the compulsory licensing clause from the
Indian Bayh-Dole Bill, Herder speculates, “If the real goal in adopting this
legislation is to attract investment from foreign firms because of a familiarity
with a Bayh-Dole like regime, then having a compulsory licensing provision
would be a cost because it is totally foreign in the U.S.”50  He further explains,
“Most of the free trade agreements the U.S. has entered into since the 1980s
have been conditioned on getting rid of compulsory licensing regimes.”51
According to Basheer, the removal of the compulsory licensing clause effec-
tively has no impact on the bill.52  Provisions of the Indian Patent Act would
apply to the Indian Bayh-Dole Bill even if it is not explicitly written into the
new legislation.53 Basheer emphasizes that the compulsory licensing provisions
in the Indian Patent Act are less than ideal and have many bottlenecks towards
implementation.54 Thus, Basheer recommends stronger public access safe-
guards in the Indian Bayh-Dole Bill, with wider compulsory licensing norms,
including removal of the three-year wait time to invoke compulsory licenses in
some cases.55
Further, Basheer recommends non-exclusive licensing provisions, particularly
with regards to platform technologies, to ensure greater access to the results of
publicly funded research.56  Guillen agrees, stating that UAEM recommends,
“global access licensing internationally, to ensure that publicly funded discov-
eries, medicines and health technologies are available at a low cost in develop-
ing countries.”57
OVER-EMPHASIS ON PATENTING
Yet another problem is the strong emphasis on patenting to the exclusion of
other forms of knowledge dissemination.  As a rationale for adopting the In-
dian Bayh-Dole Bill, proponents frequently note that only three percent of
patents filed in the Indian patent office were filed by Indian universities.58
However, according to Guillen, “This is not a good metric to go by because
just patenting something tells you nothing about whether the discovery should
have been patented, how it is eventually licensed and used, or if it was actually
licensed to the right company and will eventually benefit the public.”59  More-
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over, legal scholars argue that an over-emphasis on patenting fails to recognize
the importance of other avenues of knowledge dissemination, such as publica-
tions, conferences, and the training of students.60  Of particular concern is
whether a strong emphasis on patenting will lead to a weakened commitment
to open science, manifested in publication delays, secrecy and withholding of
data and materials.61
FUTURE OF THE BILL
With upcoming Indian elections in May 2009, the future of the Indian Bayh-
Dole Bill is unclear.  According to Basheer, the Upper House has submitted
the bill to a Parliamentary Standing Committee, which usually takes four to six
months to receive submissions and give their report to the Parliament.62
Basheer expects the Indian Bayh-Dole Bill to be enacted, even if a new admin-
istration is elected.63  Guillen concurs, noting that there is widespread support
among the government and industry groups.64
Legal scholars and public interest advocates believe that in the world’s largest
democracy, the Indian government should widen the debate to hear public
interest perspectives.65  They argue that this open approach will make it easier
to learn from the experience of the Bayh-Dole Act in the U.S. and to draw the
right lessons for India.66
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